Restless “Lower Back” in a Patient with Parkinson’s Disease by Suzuki, Keisuke et al.
Case Reports









1 Department of Neurology, Dokkyo Medical University, Tochigi, Japan, 2 Department of Neurology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan
Abstract
Background: In restless legs syndrome (RLS), the isolated involvement of other body parts in the absence of leg involvement is rare.
Case report: We report an 82-year-old male with a 1-year history of Parkinson’s disease (PD) who developed an abnormal sensation limited to his ‘‘lower back.’’
He fulfilled the four essential RLS criteria, with the major caveat that the criteria were applied in a modified manner to his lower back rather than his legs. The
administration of a dopamine agonist completely eliminated his symptoms.
Discussion: Our patient’s ‘‘restless lower back’’ may be a variant of RLS. Clinicians should pay attention to restlessness in other body parts in addition to the legs.
Keywords: Restless lower back, Parkinson’s disease, restless legs syndrome
Citation: Suzuki K, Miyamoto M, Miyamoto T, et al. Restless ‘‘lower back’’ in a patient with Parkinson’s Disease. Tremor Other Hyperkinet Mov 2013; 3:
http://tremorjournal.org/article/view/195
* To whom correspondence should be addressed. E-mail: keisuke@dokkyomed.ac.jp
Editor: Elan D. Louis, Columbia University, United States of America
Received: July 11, 2013 Accepted: August 12, 2013 Published: October 7, 2013
Copyright: ’ 2013 Suzuki et al. This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommercial–No Derivatives License, which permits
the user to copy, distribute, and transmit the work provided that the original author(s) and source are credited; that no commercial use is made of the work; and that the work is not altered
or transformed.
Conflict of interest: The authors report no conflict of interest.
Financial disclosure: None.
Introduction
Restless legs syndrome (RLS), first fully described by Ekbom, is
characterized by an urge to move the legs accompanied by abnormal leg
sensations.1 There are currently no reliable biological markers or tests
for RLS, and the diagnosis of RLS should be made when the following
four features are simultaneously present, as confirmed by a medical
interview: 1) an urge to move the legs, 2) beginning or worsening of
symptoms at rest, 3) partial or total relief by movement, 4) worsening or
occurrence of symptoms only in the evening or night.2 The diagnosis is
often difficult because it mainly relies on the subject’s complaints and
descriptions of an unpleasant sensation in the legs, which vary among
individuals.3 The pathophysiology of RLS remains unclear, but it may
be associated with central dopaminergic dysfunction, iron insufficiency,
and/or an altered endogenous opioid system.4
The parts of the leg involved vary considerably in RLS patients.
Other parts of the body, such as the arms, hips, trunk, or face, may
also be involved in RLS, particularly in severe cases.2 Although
isolated involvement of body parts other than the legs is rare, sensory
disturbances resembling RLS initially confined to the arms, abdomen,
and perineum have been described.5–8 Umehara et al9 reported a
patient who initially had abnormal sensations in the chest and back,
which subsequently extended to the arms and legs.
We report a patient with Parkinson’s disease (PD) with abnormal
sensations and restlessness confined to the lower back, thought to be a
variant of RLS.
Case report
An 82-year-old male with a 1-year history of PD complained of
difficulty falling asleep because of abnormal itching sensations in his
lower back. The patient noted an irresistible urge to move his lower
back. These sensations only occurred during night and at rest, 4–5
days per week for 1 hour per night and lasted for 3 months. He could
not resist rubbing his lower back on the bed sheet or with his fingers,
and this resulted in relief of his symptoms, during which he had no
abnormal sensations or restlessness in other parts of the body. Rocking
his lower back was also effective. There were no skin lesions. The
patient did not smoke or drink alcohol and occasionally drank caffeine-
containing beverages. He had predominantly left-sided bradykinesia
and rigidity and showed a resting tremor in the left hand while
walking. He had been treated with 100 mg L-dopa with peripheral
decarboxylase inhibitor twice daily at 6 am and 6 pm with a favorable
response for 6 months. The Hoehn and Yahr scale score was 2, and
the Unified Parkinson’s Disease Rating Scale part III score was 14.
The patient had no motor complications. His blood test results showed
mild renal dysfunction: urea nitrogen was 29.6 mg/dL (reference value
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8.0–20.0), creatinine was 1.21 mg/dL (reference value 0.65–1.09) and
the estimated glomerular filtration rate was 44.5 mL/min/1.73 m2
(reference value .60.0). The remainder of the laboratory data was
within the normal range, including liver and thyroid function and
serum iron, ferritin, folic acid, vitamin B1 and B12, and hemoglobin
levels. The abnormal sensation and restlessness in his lower back were
not associated with prolonged standing, sitting, or lying in the same
position, and changing position did not improve his symptoms,
suggesting that positional discomfort was unlikely. Other medical
conditions, such as peripheral neuropathy, radiculopathy, vascular
problems, muscle cramps, and arthritis, were unlikely in our patient.
Also, pain and motor complications, such as the wearing-off
phenomenon, dystonia, akathisia, and tardive dyskinesia, were not
observed. The patient fulfilled the four essential diagnostic criteria for
RLS, with the major caveat that the criteria were applied in a modified
manner to his lower back rather than his legs. A variant of RLS called
‘‘restless lower back’’ was considered. The administration of 0.25 mg
ropinirole at 8 pm (1 hour before bedtime) completely eliminated his
symptoms within a few days. After the 6-month follow up period,
restlessness limited to the lower back recurred once, but increasing the
dose of ropinirole to 0.5 mg resulted in immediate relief. He has not
developed restlessness in other body parts, including his legs, over an
18-month period of dopaminergic therapy.
Discussion
Ondo et al reported that 20.8% of PD patients had symptoms of
RLS. Compared with patients with isolated RLS, patients with PD
with RLS had an older age at onset and were much less likely to report
a family history of RLS. There is no evidence that RLS may
predispose to subsequent development of PD.10 Our patient had
abnormal sensations and restlessness confined to the lower back, which
was thought to be a variant of RLS, similar to restless abdomen and
arms,5,6 given that his symptoms showed an excellent response to
dopamine agonist treatment and that he fulfilled the four essential RLS
criteria with the major caveat that the criteria were applied in a
modified manner to his lower back rather than his legs. Our patient
did not show motor complications, such as dystonia, akathisia,
wearing-off phenomenon, or tardive dyskinesia over an 18-month
period of dopaminergic therapy. However, dopaminergic treatment
may either mask or augment coexisting RLS symptoms in PD,11 and
an association between long-term dopaminergic treatment and RLS
development in PD patients has been reported.12 In addition, clinical
overlap between RLS, wearing-off-related lower-limb discomfort,
restlessness, and akathisia has been suggested.11,13
RLS may involve other body parts, such as the arms and trunk.2
One-third of RLS patients have restlessness in the arms.14
Approximately 50% of 230 RLS patients had symptoms in the arms,
and in RLS patients with arm restlessness, RLS severity was greater
than in those without arm restlessness.15 Worsening of RLS symptoms
and augmentation can include other parts of the body, including the
face, arms, and trunk in addition to involvement of the legs.2 The
involvement of other body parts in the absence of the leg involvement
is rare. Table 1 shows previously reported patients with restlessness
initially confined to body parts other than the legs.5–9 Dopaminergic
therapy resulted in marked improvement of the restlessness in all
patients, supporting the hypothesis that their isolated symptoms in
other parts of the body are variants of RLS. Umehara et al9 described
a patient with restlessness initially confined to the chest and back, but
the patient’s symptoms subsequently extended to the legs. In contrast,
our patient exhibited ‘‘restless lower back’’ as the initial and confined
symptom over a follow-up period of 15 months.
Although the exact pathogenesis of RLS remains unclear, dysfunc-
tion of the dopaminergic A11 nucleus of the hypothalamus16 and brain
iron insufficiency17 have been suggested. In idiopathic RLS, positron
emission tomography/single positron emission computed tomography
(PET/SPECT) studies have not produced consistent findings of
striatonigral dopaminergic dysfunction.18,19 In contrast, the typical
motor symptoms in PD result from degeneration of the striatonigral
dopaminergic neurons as confirmed by reduced striatal uptake
observed in neuroimaging studies. In our patient, we suggest that
striatonigral and/or hypothalamic dopaminergic involvement might
have involved a projection to the T10-L2 spinal segments, resulting in
abnormal sensations in the lower back. This hypothesis is in agreement
with the suggestion that the T7–12 spinal segments may account for
the restless abdomen.6 However, why selective involvement of spinal
segments corresponding to the lower back occurred in our patient is
unclear. In PD, pain of central origin may involve restlessness, and
unusual pain syndromes involving many parts of the body have been
reported.20 Parkinsonian akathisia is thought to result from a
dopaminergic deficiency involving the mesocortical pathway, which
originates in the ventral tegmental area.20 Ondo recently described
two patients showing semi-rhythmic leg movements that mimicked
myoclonus.21 The patients denied having any urge to move or
abnormal sensations in the legs; however, the leg movements partially
improved while standing and dramatically improved with pramipexole
treatment, suggesting that these patients may represent the isolated
motor component of RLS in the setting of spinal cord pathology.
Moreover, restlessness in the legs without fulfilling RLS criteria,
referred to as ‘‘leg motor restlessness,’’ has been reported to be more
frequent in untreated PD patients than in controls. It remains an open
question whether patients with leg motor restlessness (but not fulfilling
RLS diagnostic criteria) develop full-blown RLS.22
In conclusion, physicians should be aware that RLS-related
restlessness can occur in other parts of the body in the absence of
episodes of worsening or augmentation of restlessness. The diagnosis of
a variant of RLS would be of great importance in view of the
significant response to dopaminergic treatment, which considerably
ameliorates patients’ sleep problems and improves their quality of life.
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